Global Albumin Usage in 2023 & Forecast to 2030
an analysis of the GLOBAL albumin MARKET IN 2023
AND FORECAST TO THE YEAR 2030
Albumin is the second most important plasma protein by sales, after immunoglobulins, and is one of the two last liter products as it is made from which every plasma liter fractionated. It is also the most globalized protein, meaning a broader distribution of sales across countries and regions than any other plasma protein. Global sales of albumin for human therapeutic use were over $5 billion in 2022.
It is precisely because albumin is produced for every liter of plasma along with immunoglobulins that it is critical to understand its current usage and future demand growth for this product. As the plasma industry continues to collect and fractionate more plasma to satisfy the expected demand of IG, will albumin demand keep pace? This question is addressed in this report, along with other questions such as: How is albumin used in western countries (North America and Europe) compared to albumin’s usage in eastern countries (China and Asia)? Where will albumin usage grow the fastest, and what is forecast to happen in China, the world’s largest albumin market? In mature markets in Europe, will albumin grow, and if so, how fast? Will the price of albumin rise, and by how much on an annual basis?
This new report takes a deep look at current albumin usage around the globe, and details how albumin is used by medical specialty and key indications across all five geographic regions (North America, Europe, Asia/Pacific, Middle East/Africa and Latin America,). MRB’s forecast model analyzes both key drivers of albumin growth and how these trends will effect future growth, taking into account how the interaction of plasma supply and albumin demand can be expected to influence price patterns globally over the next 7 years. This report identifies albumin usage in over 100 countries in 2022 and 2023. Assumptions used to forecast albumin unit volume and pricing are based on (1) actual MRB sales data collected in 100 countries globally, (2) expert opinions on albumin usage across all five regions, (3) MRB’s analysis of future demographic and disease trends which affect albumin demand plasma supply, and (4) plasma supply and albumin pricing dynamics.
See the complete Table of Contents below for more details about the contents of this report.
TABLE OF CONTENTS
EXECUTIVE SUMMARY 5
- INTRODUCTION 16
Discovery of Human Albumin and the Beginning of the Plasma Fractionation Industry 16
Human Albumin and Plasma Economics over the Decades 17
Human Albumin for Non-therapeutic Applications 18
History of Albumin Demand and Price 19
Overview of the Clinical Use of Albumin 21
- FORECAST ASSUMPTIONS 25
- NORTH AMERICA ALBUMIN USAGE & FORECAST 32
2023 Albumin Usage in North America 32
2013 Analysis of Albumin Usage by Indication in North America 33
Current Albumin Usage by Indication in the United States 36
Cardiovascular Disease/Circulatory System Albumin Usage 37
Infectious Diseases (Sepsis) and Albumin Usage 37
Digestive System Diseases (Cirrhosis) Albumin Usage 38
Genitourinary Diseases (Kidney Failure) Albumin Usage 41
Cancer Albumin Usage 42
Trauma (injuries, burns, etc.) Albumin Usage 42
Other Diseases with Albumin Usage 44
Selective Publications Regarding Albumin Usage in North America 44
Forecast to 2030 in North America 54
Growth Drivers of Albumin Usage over the Forecast Period 56
Sales in Dollars and Price Expectations to 2030 64
- EUROPE ALBUMIN USAGE & FORECAST 66
2023 Albumin Usage in Europe 66
Current Albumin Usage by Indication in Europe 70
Selected Publications Reporting Albumin Clinical Trials in Europe 78
Forecast to 2030 in Europe 86
Growth Drivers of Albumin Usage over the Forecast Period 90
Sales in Dollars and Price Expectations to 2030 96
- ASIA AND PACIFIC ALBUMIN USAGE & FORECAST 98
2023 Albumin Usage in Asia & Pacific 98
China Albumin Usage 100
Current Albumin Usage by Indication in Asia & Pacific 103
Current albumin Usage by Indications in China 103
Albumin Usage by Indication in other Asia & Pacific countries 104
Selective Publications Regarding Albumin Usage in Asia Pacific 105
China 105
Other Asia & Pacific countries 109
Forecast to 2030 in Asia & Pacific 113
China Forecast to 2030 121
- MIDDLE EAST AND AFRICA ALBUMIN USAGE & FORECAST 125
2023 Albumin Usage in Middle East & Africa 125
Current Albumin Usage by Indication in Middle East & Africa 127
Forecast to 2030 in Middle East & Africa 136
Growth Drivers of Albumin Usage over the Forecast Period 141
Sales in Dollars and Price Expectations to 2030 145
- LATIN AMERICA ALBUMIN USAGE & FORECAST 147
2023 Albumin Usage in Latin America 147
Current Albumin Usage by Indication in Latin America 148
Forecast to 2030 in Latin America 153
Growth Drivers of Albumin Usage over the Forecast Period 157
Sales in Dollars and Price Expectations to 2030 160
- WORLDWIDE ALBUMIN USAGE & FORECAST 162
2023 Global Albumin Usage 162
Global Albumin Forecast from 2023 to 2030 168
Yearly Growth in Units, Pricing and dollars 168
2030 Global Albumin Usage 171
Underlying Global Albumin Growth Drivers 173
Implications of Global Albumin Produced (Supply) vs. Forecasted Demand: Plasma Economics 174
Impact of China on Global Albumin Usage and Growth 176